Investigating a protein's role in cholesterol transport and fatty liver disease
An ER Stress Inducible START Domain Cholesterol Transport Protein, StarD5; and Unique Role in Fatty Liver Disease
This study is looking at how a protein called StarD5 affects cholesterol movement in liver cells and how this relates to fatty liver disease, with the hope of finding new ways to help manage liver health for people dealing with this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Veterans Administration Hospital NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-10951505 on NIH RePORTER |
What this research studies
This research focuses on understanding how a specific protein, StarD5, influences cholesterol transport within liver cells and its connection to fatty liver disease. The study aims to explore the molecular mechanisms behind the progression of nonalcoholic fatty liver disease (NAFLD) to more severe liver conditions, such as inflammation and cirrhosis. By examining how StarD5 is affected by endoplasmic reticulum (ER) stress, the research seeks to uncover potential therapeutic targets for managing cholesterol levels and liver health. Patients may benefit from insights that could lead to new treatments for fatty liver disease and its complications.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with nonalcoholic fatty liver disease or those at risk of developing liver complications due to cholesterol metabolism issues.
Not a fit: Patients with liver diseases unrelated to cholesterol metabolism or those who do not have fatty liver disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating fatty liver disease and its progression to more severe liver conditions.
How similar studies have performed: Other research has shown promising results in understanding cholesterol metabolism and its impact on liver health, suggesting that this approach could yield valuable insights.
Where this research is happening
Richmond, United States
- VA Veterans Administration Hospital — Richmond, United States (Active)
Researchers
- Principal investigator: Pandak, William M — VA Veterans Administration Hospital
- Study coordinator: Pandak, William M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.